Anti-HMGB1 as Potential Therapeutics for NMO

被引：0
|
作者：
Chin, Li-Te [1 ]
机构：
[1] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
L-13
引用
收藏
页码：803 / 803
页数：1
相关论文
共 50 条
  • [31] PROTECTIVE EFFECT OF ANTI-HMGB1 ANTIBODY AGAINST CHRONIC CYCLOSPORINE NEPHROTOXICITY IN A MOUSE MODEL
    Suk, Park Hoon
    Nim, Kim Eun
    Young, Kim Min
    Hee, Lim Ji
    Hyun, Yu Ji
    Deuk, Hwang Seun
    Whee, Park Cheol
    Soon, Choi Bum
    NEPHROLOGY, 2014, 19 : 119 - 119
  • [32] ANTI-HMGB1 MONOCLONAL ANTIBODY AMELIORATES IMMUNE DYSFUNCTION AFTER PERIPHERAL TISSUE TRAUMA
    Darwiche, S. S.
    Ruan, X.
    Zettel, K. R.
    Cai, C.
    Pape, H.
    Billiar, T.
    SHOCK, 2013, 39 : 40 - 40
  • [33] The effect of anti-HMGB1 antibody on collagenase-induced intracerebral hemorrhage in rats
    Ryu, Katsuyaku
    Wang, Dengli
    Wake, Hidenori
    Teshigawara, Kiyoshi
    Takahashi, Hideo
    Mori, Shuji
    Nishibori, Masahiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 189P - 189P
  • [34] The western-type diet induces anti-HMGB1 autoimmunity in Apoe-/- mice
    Pan, Yue
    Ke, Hanzhong
    Yan, Zhaoqi
    Geng, Yajun
    Asner, Nathan
    Palani, Sunil
    Munirathinam, Gnanasekar
    Dasari, Subramanyam
    Nitiss, Karin C.
    Bliss, Sarah
    Patel, Priyanka
    Shen, Hongming
    Reardon, Catherine A.
    Getz, Godfrey S.
    Chen, Aoshuang
    Zheng, Guoxing
    ATHEROSCLEROSIS, 2016, 251 : 31 - 38
  • [35] High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
    Abdulahad, Deena A.
    Westra, Johanna
    Bijzet, Johannes
    Limburg, Pieter C.
    Kallenberg, Cees G. M.
    Bijl, Marc
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)
  • [36] CONTROLLING INFLAMMATION BY INHIBITING HMGB1/RAGE-MEDIATED ENDOCYTOSIS USING ANTI-HMGB1 ANTIBODIES OR HMGB1-SPECIFIC ANTAGONIST BOX A
    Yang, Huan
    Liu, Hui
    Zeng, Qiong
    Gunasekaran, Manoj K.
    Chavan, Sangeeta S.
    Andersson, Ulf
    Tracey, Kevin J.
    SHOCK, 2019, 51 (06): : 54 - 54
  • [37] High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
    Deena A Abdulahad
    Johanna Westra
    Johannes Bijzet
    Pieter C Limburg
    Cees GM Kallenberg
    Marc Bijl
    Arthritis Research & Therapy, 13
  • [38] Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
    Yang, Huan
    Liu, Hui
    Zeng, Qiong
    Imperato, Gavin H.
    Addorisio, Meghan E.
    Li, Jianhua
    He, Mingzhu
    Cheng, Kai Fan
    Al-Abed, Yousef
    Harris, Helena E.
    Chavan, Sangeeta S.
    Andersson, Ulf
    Tracey, Kevin J.
    MOLECULAR MEDICINE, 2019, 25 (1)
  • [39] Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
    Huan Yang
    Hui Liu
    Qiong Zeng
    Gavin H. Imperato
    Meghan E. Addorisio
    Jianhua Li
    Mingzhu He
    Kai Fan Cheng
    Yousef Al-Abed
    Helena E. Harris
    Sangeeta S. Chavan
    Ulf Andersson
    Kevin J. Tracey
    Molecular Medicine, 2019, 25
  • [40] SUCCESSFUL THERAPY WITH ANTI-HMGB1 MONOCLONAL ANTIBODIES IN TWO SEPARATE EXPERIMENTAL ARTHRITIS MODELS
    Schierbeck, Hanna
    Lundback, Peter
    Palmblad, Karin
    Klevenvall, Lena
    Li, Jian Hua
    Chavan, Sangeeta
    Yang, Huan
    Harris, Helena Erlandsson
    Andersson, Ulf
    Ottosson, Lars
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
12345